Cytokinetics, Incorporated (CYTK)
NASDAQ · Healthcare
Cytokinetics, Incorporated Long Term Debt 2009–2025
Cytokinetics, Incorporated annual long term debt history from 2015 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Cytokinetics, Incorporated long term debt as of December 31, 2025: 246.4M, a 60.23% decrease year-over-year.
- Cytokinetics, Incorporated long term debt for 2025 were 246.4M, a 60.23% decrease from 2024.
- Cytokinetics, Incorporated long term debt for 2024 were 619.5M, a 3.09% decrease from 2023.
- Cytokinetics, Incorporated long term debt for 2023 were 639.3M, a 1.58% decrease from 2022.
- Cytokinetics, Incorporated long term debt for 2022 were 649.6M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cytokinetics, Incorporated Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $246 |
| 2024 | $620 |
| 2023 | $639 |
| 2022 | $650 |
| 2021 | $47 |
| 2020 | $46 |
| 2019 | $45 |
| 2018 | $42 |
| 2017 | $32 |
| 2016 | $30 |
| 2015 | $15 |
Cytokinetics, Incorporated Long Term Debt — FAQ
Cytokinetics, Incorporated (CYTK) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CYTK's long term debt history?
The chart and table above show Cytokinetics, Incorporated's long term debt by year and by quarter, including the growth rate.